EE200100151A - Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga - Google Patents

Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga

Info

Publication number
EE200100151A
EE200100151A EEP200100151A EEP200100151A EE200100151A EE 200100151 A EE200100151 A EE 200100151A EE P200100151 A EEP200100151 A EE P200100151A EE P200100151 A EEP200100151 A EE P200100151A EE 200100151 A EE200100151 A EE 200100151A
Authority
EE
Estonia
Prior art keywords
active ingredient
dry powder
pulmonary delivery
pulmonary
delivery
Prior art date
Application number
EEP200100151A
Other languages
English (en)
Estonian (et)
Inventor
Clark Andrew
Kuo Mei-Chang
Lalor Cecily
John Aldous Barry
Original Assignee
Inhale Therapeutic Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Systems, Inc. filed Critical Inhale Therapeutic Systems, Inc.
Publication of EE200100151A publication Critical patent/EE200100151A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
EEP200100151A 1998-09-14 1999-09-13 Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga EE200100151A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
EE200100151A true EE200100151A (et) 2002-06-17

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100151A EE200100151A (et) 1998-09-14 1999-09-13 Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga

Country Status (44)

Country Link
EP (1) EP1117442A1 (lt)
JP (1) JP2002524535A (lt)
KR (1) KR20010075063A (lt)
CN (1) CN1317977A (lt)
AP (1) AP1374A (lt)
AR (1) AR022090A1 (lt)
AU (1) AU753014B2 (lt)
BG (1) BG105430A (lt)
BR (1) BR9913722A (lt)
CA (1) CA2343920A1 (lt)
CO (1) CO5130023A1 (lt)
CZ (1) CZ2001829A3 (lt)
DZ (1) DZ2892A1 (lt)
EA (1) EA003476B1 (lt)
EE (1) EE200100151A (lt)
GE (1) GEP20043257B (lt)
GT (1) GT199900156A (lt)
HK (1) HK1042231A1 (lt)
HN (1) HN1999000159A (lt)
HR (1) HRP20010189A2 (lt)
HU (1) HUP0103837A3 (lt)
ID (1) ID28845A (lt)
IL (2) IL141562A0 (lt)
IS (1) IS5878A (lt)
LT (1) LT4897B (lt)
LV (1) LV12658B (lt)
MA (1) MA25590A1 (lt)
MY (1) MY129282A (lt)
NO (1) NO20011251L (lt)
NZ (1) NZ510168A (lt)
OA (1) OA11781A (lt)
PA (1) PA8481901A1 (lt)
PE (1) PE20001061A1 (lt)
PL (1) PL195574B1 (lt)
SA (1) SA99200718B1 (lt)
SK (1) SK3442001A3 (lt)
TN (1) TNSN99173A1 (lt)
TR (1) TR200101182T2 (lt)
TW (1) TWI226248B (lt)
UA (1) UA76085C2 (lt)
UY (1) UY25711A1 (lt)
WO (1) WO2000015262A1 (lt)
YU (1) YU24201A (lt)
ZA (1) ZA200101995B (lt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
HK1049621A1 (zh) 1999-06-09 2003-05-23 罗伯特‧E‧希弗斯 超临界流体辅助的喷雾和鼓泡乾燥
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
JP2005503425A (ja) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
AU2002352836B2 (en) 2001-11-20 2005-09-29 Alkermes, Inc. Improved particulate compositions for pulmonary delivery
CA2477245A1 (en) 2002-02-25 2003-09-04 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
WO2004004798A2 (en) * 2002-07-03 2004-01-15 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN101098678A (zh) 2004-04-23 2008-01-02 锡德克斯公司 含有磺基烷基醚环糊精的dpi制剂
EP2540696B1 (en) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
BRPI0608844A2 (pt) * 2005-03-09 2010-02-02 Ono Pharmaceutical Co partìcula e preparação que contém a partìcula
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
PT2583668E (pt) 2005-10-26 2015-01-05 Cydex Pharmaceuticals Inc Composições de éter sulfoalquílico de ciclodextrina e métodos para a sua preparação
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
JP5315056B2 (ja) * 2006-10-25 2013-10-16 大日本住友製薬株式会社 固結抑制粒状製剤
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
CN101687757A (zh) 2007-04-13 2010-03-31 扩散药品有限公司 双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
KR20100083820A (ko) 2007-10-31 2010-07-22 디퓨젼 파마슈티컬즈 엘엘씨 저분자 확산을 촉진시키는 신규한 치료요법
ES2661215T3 (es) 2009-05-20 2018-03-28 Aeras Composiciones víricas; inmunógenas; secadas por pulverización; estables
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
AU2011262361A1 (en) 2010-06-02 2013-01-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
KR102240042B1 (ko) * 2012-05-03 2021-04-14 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
MX392636B (es) 2014-10-31 2025-03-24 Glaxosmithkline Ip Dev Ltd Formulacion en polvo.
CA3018550A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
CA2277801C (en) * 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
KR20010075063A (ko) 2001-08-09
TR200101182T2 (tr) 2001-09-21
NZ510168A (en) 2003-09-26
CO5130023A1 (es) 2002-02-27
ID28845A (id) 2001-07-05
MY129282A (en) 2007-03-30
OA11781A (en) 2005-07-26
HUP0103837A3 (en) 2002-11-28
NO20011251D0 (no) 2001-03-13
BG105430A (en) 2001-12-29
YU24201A (sh) 2003-08-29
AR022090A1 (es) 2002-09-04
AU753014B2 (en) 2002-10-03
LT2001021A (lt) 2001-11-26
EA003476B1 (ru) 2003-06-26
EP1117442A1 (en) 2001-07-25
PL195574B1 (pl) 2007-10-31
IL141562A (en) 2007-07-24
AP2001002093A0 (en) 2001-03-31
MA25590A1 (fr) 2002-12-31
TWI226248B (en) 2005-01-11
SK3442001A3 (en) 2001-11-06
LT4897B (lt) 2002-02-25
CZ2001829A3 (cs) 2001-09-12
PL346768A1 (en) 2002-02-25
LV12658B (lv) 2001-09-20
UY25711A1 (es) 1999-11-17
JP2002524535A (ja) 2002-08-06
EA200100300A1 (ru) 2001-10-22
WO2000015262A1 (en) 2000-03-23
NO20011251L (no) 2001-04-17
IL141562A0 (en) 2002-03-10
TNSN99173A1 (fr) 2005-11-10
GEP20043257B (en) 2004-06-25
GT199900156A (es) 2001-03-07
AP1374A (en) 2005-02-28
ZA200101995B (en) 2002-03-11
HRP20010189A2 (en) 2005-04-30
LV12658A (lv) 2001-05-20
UA76085C2 (en) 2006-07-17
IS5878A (is) 2001-03-05
SA99200718B1 (ar) 2006-11-04
BR9913722A (pt) 2001-05-29
PE20001061A1 (es) 2000-10-08
CN1317977A (zh) 2001-10-17
HK1042231A1 (zh) 2002-08-09
HUP0103837A2 (hu) 2002-05-29
DZ2892A1 (fr) 2003-12-15
HN1999000159A (es) 1999-11-11
PA8481901A1 (es) 2002-04-25
AU6039799A (en) 2000-04-03
CA2343920A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
EE200100151A (et) Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga
DE60035911D1 (de) Trockenpulverinhalator
DE60141579D1 (de) Trockenpulver-Inhalator
FI19991852L (fi) Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
EE200100212A (et) Toimeaine kohaletoimetamine aerosoolina moduleeritud takistusega õhuvooluga
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
EE200100185A (et) Asendatud fenüülderivaadid, nende valmistamine jakasutamine
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
EE04219B1 (et) Säilituskindel toimeainekontsentraat formoterooliga
DE60039829D1 (de) Pulversprühpistole
IS4364A (is) Innöndunarbúnaður fyrir þurrduft
NL350038I1 (nl) Herbicidaal actieve 3-hydroxy-4-aryl-5-oxopyrazoline derivaten
NO20012915L (no) Ny farmasöytisk formulering
HUP0400723A3 (en) Isoxazoline derivatives and herbicide composition comprising the same as active ingredient
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
DE60000808D1 (de) Fliessbare Pestizide Öl-in-Wasser Formulierungen

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner